Staff turnover in EUR307,778316,754320,326321,359338,154
Staff turnover in EUR307,778316,754320,326321,359338,154
The share: stated in EUR20212022202320242025
Shares outstanding (in mn.)0.390.391.58156.571.55
Dividend per share1.281.280.320.320.32
Basic earnings per share0.871.661.761.050.46
P/L in EUR million under IAS/IFRS20212022202320242025
Turnover931.01,105.61,136.71,159.11,219.6
Operating income (EBIT)146.3273.5300.8181.998.2
Earnings before taxes148.2301.4338.7185.798.5
Annual net profit/ loss140.3271.9285.2168.173.4
Balance sheet in EUR million under IAS/IFRS20212022202320242025
Assets
Total current assets510.6605.6621.5617.4608.3
Total fixed assets1,839.21,765.52,112.22,195.81,949.6
Total assets2,349.82,371.02,733.72,813.22,557.9
Liabilities
Total short-term liabilities152.3176.0128.5159.4175.8
Total long-term liabilities626.3494.0638.7585.0463.2
Total provisions0.00.00.00.00.0
Equity capital1,571.21,701.01,966.52,068.81,918.8
Total liabilities2,349.82,371.02,733.72,813.22,557.9
Management:
Robert Baumgartner
Alpna Seth
Amy Herr
Joseph Keegan
Judith Klimovsky
Rupert Vessey
John Higgins
Julie Bushman
Kim Kelderman
Cheryl Bethune
Gary Latham
Jim Hippel
Shane Bohnen
Board:
Shareholding in %:
Address: 614 McKinley Place NE, 55413-2610 Minneapolis
T: +1-612-379-8854
F: +
I: http://www.bio-techne.com
E: [email protected]